{"pmcid": 4987981, "prompt_strategy": "direct", "model": "claude-opus-4-5", "extractions": [{"outcome": "PASI mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 3.9, "comparator_mean": 1.7, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "PASI mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 4.3, "comparator_mean": 1.7, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "ESI mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 4.2, "comparator_mean": 2.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "ESI mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 4.3, "comparator_mean": 2.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "PGA mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 2.3, "comparator_mean": 1.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "PGA mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 2.3, "comparator_mean": 1.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "percentage of patients achieving 75% reduction in PASI", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 85.7, "comparator_mean": 4.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "percentage of patients achieving 75% reduction in PASI", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 81.3, "comparator_mean": 4.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "percentage of patients achieving 75% reduction in ESI", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 61.9, "comparator_mean": 8.7, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "percentage of patients achieving 75% reduction in ESI", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 56.2, "comparator_mean": 8.7, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "FPG mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 15.2, "comparator_mean": 2.2, "intervention_standard_deviation": 19.2, "comparator_standard_deviation": 10.0, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "FPG mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 20.5, "comparator_mean": 2.2, "intervention_standard_deviation": 17.4, "comparator_standard_deviation": 10.0, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "total cholesterol mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 21.8, "comparator_mean": 1.4, "intervention_standard_deviation": 25.2, "comparator_standard_deviation": 29.2, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "total cholesterol mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 24.0, "comparator_mean": 1.4, "intervention_standard_deviation": 29.5, "comparator_standard_deviation": 29.2, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "triglycerides mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 21, "comparator_group_size": 23, "intervention_mean": 44.3, "comparator_mean": 1.1, "intervention_standard_deviation": 45.4, "comparator_standard_deviation": 43.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "triglycerides mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 16, "comparator_group_size": 23, "intervention_mean": 53.3, "comparator_mean": 1.1, "intervention_standard_deviation": 36.9, "comparator_standard_deviation": 43.3, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "IL-6 mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 7, "comparator_group_size": 10, "intervention_mean": -75.7, "comparator_mean": -24.21, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "IL-6 mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 9, "comparator_group_size": 10, "intervention_mean": -0.8, "comparator_mean": -24.21, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "TNF-α mean change", "intervention": "metformin", "comparator": "placebo", "intervention_group_size": 7, "comparator_group_size": 10, "intervention_mean": -41.5, "comparator_mean": -201.1, "pmcid": "PMC4992225", "outcome_type": "continuous"}, {"outcome": "TNF-α mean change", "intervention": "pioglitazone", "comparator": "placebo", "intervention_group_size": 9, "comparator_group_size": 10, "intervention_mean": -196.6, "comparator_mean": -201.1, "pmcid": "PMC4992225", "outcome_type": "continuous"}], "errors": []}
